These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22728548)

  • 1. [Novel strategy for GVHD treatment: possible use of mesenchymal stem cells and interleukin-21].
    Ozaki K
    Rinsho Ketsueki; 2012 May; 53(5):483-6. PubMed ID: 22728548
    [No Abstract]   [Full Text] [Related]  

  • 2. Encapsulated mesenchymal stem cells for in vivo immunomodulation.
    Zanotti L; Sarukhan A; Dander E; Castor M; Cibella J; Soldani C; Trovato AE; Ploia C; Luca G; Calvitti M; Mancuso F; Arato I; Golemac M; Jonjic N; Biondi A; Calafiore R; Locati M; D'Amico G; Viola A
    Leukemia; 2013 Feb; 27(2):500-3. PubMed ID: 22878604
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.
    Mannon PJ
    Expert Opin Biol Ther; 2011 Sep; 11(9):1249-56. PubMed ID: 21787241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
    Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
    Lancet; 2004 May; 363(9419):1439-41. PubMed ID: 15121408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
    Lucchini G; Introna M; Dander E; Rovelli A; Balduzzi A; Bonanomi S; Salvadè A; Capelli C; Belotti D; Gaipa G; Perseghin P; Vinci P; Lanino E; Chiusolo P; Orofino MG; Marktel S; Golay J; Rambaldi A; Biondi A; D'Amico G; Biagi E
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1293-301. PubMed ID: 20350611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells for graft-versus-host disease: a double edged sword?
    Vianello F; Dazzi F
    Leukemia; 2008 Mar; 22(3):463-5. PubMed ID: 18335000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research progress on immunologic mechanisms of mesenchymal stem cells for treatment of graft-versus-host disease].
    Wang RP; Chen H; Guo YQ; Wu RN; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):550-3. PubMed ID: 21518528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells for graft-versus-host disease.
    Tolar J; Villeneuve P; Keating A
    Hum Gene Ther; 2011 Mar; 22(3):257-62. PubMed ID: 21288086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells as treatment for chronic GVHD.
    Ringden O; Keating A
    Bone Marrow Transplant; 2011 Feb; 46(2):163-4. PubMed ID: 21307841
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tissue regeneration and immunosuppression by mesenchymal stem cells].
    Lorenz HM; Ho AD
    Dtsch Med Wochenschr; 2006 Apr; 131(16):892-5. PubMed ID: 16625484
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplanted mesenchymal stem cells can inhibit the three developmental stages of murine acute graft-versus-host disease.
    Li H; Guo Z; Zhu H; Li XS; Jiang X; Yao H; Wang X; Liao L; Liu Y; Wu Y; Zhang Y; Mao N
    In Vivo; 2010; 24(5):659-66. PubMed ID: 20952730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose.
    Subbanna PK
    Med Hypotheses; 2007; 69(2):469-70. PubMed ID: 17324528
    [No Abstract]   [Full Text] [Related]  

  • 17. CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease.
    Chen W; Li M; Li Z; Yan Z; Cheng H; Pan B; Cao J; Chen C; Zeng L; Xu K
    Immunol Lett; 2012 Apr; 143(2):161-9. PubMed ID: 22342854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring.
    Dander E; Lucchini G; Vinci P; Introna M; Masciocchi F; Perseghin P; Balduzzi A; Bonanomi S; Longoni D; Gaipa G; Belotti D; Parma M; Algarotti A; Capelli C; Golay J; Rovelli A; Rambaldi A; Biondi A; Biagi E; D'Amico G
    Leukemia; 2012 Jul; 26(7):1681-4. PubMed ID: 22289986
    [No Abstract]   [Full Text] [Related]  

  • 19. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
    Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
    Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy by allogeneic stem cell transplantation.
    Ringdén O
    Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.